Healthcare -
Biotechnology - NASDAQ - US
$ 45.07
0.625 %
$ 2.61 B
Market Cap
-38.52
P/E
JANX - SHORT-TERM DEBT
Short-term Debt JANX - Janux Therapeutics, Inc.
1.52 M
LAST VALUE
97.73%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR